Connect Education Workshops About Marginal Zone Lymphoma

Upcoming Workshops

1. Dec14

   Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
   Register

Past Workshops

1. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
   Tags:

   cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatargeted treatmentstreatment
2. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
   Tags:

   colorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomanon-hodgkin lymphomapancreatic cancerperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialspainside effectstreatment
3. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
   Tags:

   cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatment
4. What’s New in Precision Medicine
   Tags:

   breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapytargeted treatments
5. Update on CAR T-Cell Therapies
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomacar t-cell therapyimmunotherapytargeted treatmentstreatment
6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
7. Non-Hodgkin Lymphoma: Current Treatment Progress
   Tags:

   cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatargeted treatmentstreatment
8. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatment
9. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
   Tags:

   cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatment
10. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    Tags:

    acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
11. What’s New In Precision Medicine
    Tags:

    breast cancerchronic lymphocytic leukemiachronic myelogenous leukemiacolorectal cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersdiagnostic testsgenomics
12. Update On Marginal Zone Lymphoma (MZL)
    Tags:

    cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaside effectstreatment
13. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    Tags:

    cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentadherencebiosimilarschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatments
14. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    Tags:

    acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatment
15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    Tags:

    acute lymphoblastic leukemiaacute myeloid leukemiabone cancerchronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomabone healthbone marrow transplanttreatmentclinical trials
16. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    Tags:

    acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomamultiple myelomaadherencetreatment
17. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)Part II of Living with Mantle Cell Lymphoma (MCL)
    Tags:

    cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomacare planningcaregiving
18. Marginal Zone Lymphoma (MZL): Treatment Updates
    Tags:

    lymphomamarginal zone lymphomatreatment
19. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    Tags:

    leukemialymphomamultiple myelomamyeloproliferative neoplasmsacute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomamyelodysplastic syndromesmyelofibrosispolycythemia verabiomarkersdiagnostic teststreatmentgenomicspersonalized medicine
20. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    Tags:

    acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
21. Update on Marginal Zone Lymphoma (MZL)
    Tags:

    lymphomamarginal zone lymphomatreatment
22. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    Tags:

    hodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatment
23. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    Tags:

    cutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomaperipheral t-cell lymphomatreatment
24. Update on CAR T-Cell Therapies
    Tags:

    acute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyelofibrosismyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomapolycythemia verasmall lymphocytic lymphomatreatmentimmunotherapycar t-cell therapypersonalized medicine
25. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    Tags:

    hodgkin lymphomalymphomamantle cell lymphomamarginal zone lymphomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomawaldenstrom’s macroglobulinemiatreatment
26. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    Tags:

    lymphomamultiple myelomamyeloproliferative neoplasmsacute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemiamantle cell lymphomamarginal zone lymphomamyelodysplastic syndromesmyelofibrosisnon-hodgkin lymphomaperipheral t-cell lymphomapolycythemia verasmall lymphocytic lymphomaadherencetreatment
27. Taking Your Blood Cancer Treatment on Schedule
    Tags:

    leukemiamultiple myelomamyeloproliferative neoplasmslymphomaacute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomamantle cell lymphomamarginal zone lymphomamyelodysplastic syndromesmyelofibrosisnon-hodgkin lymphomaperipheral t-cell lymphomapolycythemia verasmall lymphocytic lymphomatreatmentadherence